Ingredient Research

MAG-O3® Monoglyceride Omega-3

Clinical Research, Mechanism & Applications

Omega-3EPADHABioavailabilityMonoglyceride

At a Glance

Ingredient Form

Monoglyceride omega-3 (EPA/DHA)

Primary Research Areas

Absorption • Bioavailability • Lipid Transport

Research Level

Clinical + Pharmacokinetic Evidence

Distinctive Characteristic

sn-2 monoglyceride positioning of fatty acids

What Is Monoglyceride Omega-3?

MAG-O3 is a monoglyceride (MAG) form of omega-3 in which EPA and DHA fatty acids are positioned on the sn-2 glycerol position as free monoglycerides rather than re-esterified triglycerides or ethyl esters. In the digestive tract, sn-2 monoglycerides are absorbed directly through the enterocyte without the full pancreatic lipase digestion sequence required for triglyceride oils. Because absorption does not depend on the same enzymatic re-assembly steps, monoglyceride omega-3 is studied as a highly bioavailable delivery form. Wellnex selects monoglyceride omega-3 for formulations where efficient absorption of EPA and DHA and a smaller, easier-to-tolerate dose are priorities. The form is particularly relevant for individuals with reduced digestive capacity, fat-malabsorption concerns, or those seeking a lower-volume fish oil option without compromising EPA/DHA delivery.

Understanding Omega-3 Forms

Commercial fish oil is sold in four principal forms. Ethyl ester (EE) concentrates EPA and DHA by bonding them to ethanol, improving concentration but requiring pancreatic enzymes to hydrolyze before absorption, which can reduce bioavailability. Triglyceride (TG) is the natural fish oil structure. Re-esterified triglyceride (rTG) re-bonds concentrated EPA/DHA back onto a glycerol backbone after concentration, generally improving absorption over EE. Monoglyceride (MAG), the form used in MAG-O3, presents EPA and DHA already hydrolyzed on the sn-2 position, allowing direct uptake across the intestinal wall and re-assembly into chylomicrons. Form comparison studies, including pharmacokinetic trials, consistently show absorption differences between these forms; monoglyceride is positioned as the most directly absorbable. For formulators these differences matter when the goal is maximizing EPA/DHA delivery per dose, lowering the pill burden, or supporting patients with compromised digestion.

Research Highlights

Pharmacokinetic Studies

Absorption & Bioavailability

Comparative pharmacokinetic research positions monoglyceride omega-3 as the most directly absorbable of the common EPA/DHA delivery forms.

Human Research

Omega-3 Index

Studies measure increases in the Omega-3 Index and shifts in the AA:EPA ratio following monoglyceride omega-3 supplementation.

Mechanistic Research

Lipid Transport

Direct enterocyte uptake of sn-2 monoglycerides supports efficient chylomicron assembly and EPA/DHA transport.

Evidence Distinction

Research labeled “Branded Ingredient Study” used the named branded material. Research labeled “Ingredient-Level Research” studied the nutrient or ingredient class generally and is informative without implying the same exact material was used. We do not imply a study used a branded ingredient unless the publication identifies it.

PubMed Research

Human TrialBranded Ingredient StudyEmerging

MAG-DHA (monoglyceride docosahexaenoic acid) corrects AA/DHA imbalance and reduces inflammatory mediators in cystic fibrosis: a randomized double-blind pilot trial

Marine Drugs, 2018

DHA in MAG-O3 is absorbed even in the absence of digestive enzymes, correcting the AA/DHA imbalance while possibly exerting anti-inflammatory properties.

Population:Adult outpatients with cystic fibrosis, 18–48 y

Participants:15

Duration:60 days

Dose:5 g/day MAG-DHA (8 × 625 mg softgels) vs placebo

Primary Area:Erythrocyte fatty-acid profile & inflammatory mediators

Key Finding

MAG-DHA increased erythrocyte DHA, reduced the AA/DHA ratio, and reduced plasma human leukocyte elastase (pHLE) complexes and IL-6 expression.

View on PubMed

PharmacokineticBranded Ingredient StudyStrong

Monoglyceride omega-3 (MAG-OM3) increases coenzyme Q10 bioavailability compared to CoQ10 alone: a randomized crossover trial

Journal of Nutritional Science, 2022

CoQ10 absorption was approximately 2× higher when combined with MAG-O3 vs a single dose of CoQ10 alone.

Population:Healthy adults

Participants:30 (15 men, 15 women)

Duration:48-h pharmacokinetics

Dose:200 mg CoQ10 with MAG-OM3, rice oil, or alone

Primary Area:CoQ10 bioavailability & absorption

Key Finding

The 48-h AUC of plasma CoQ10 was ~2× higher when provided with MAG-OM3 or rice oil than alone; a sex-by-treatment interaction was observed in the postprandial window.

View on PubMed

RCTBranded Ingredient StudyStrong

Comparison of pharmacokinetics of omega-3 fatty acid supplements in MAG-O3 or ethyl ester in humans with a regular meal: a randomized controlled trial

Lipids in Health and Disease, 2020

In a randomized crossover trial, 3 g of EPA+DHA as monoglyceride (MAG-O3) was absorbed at least 3× better than the dose-equivalent ethyl ester fish oil, even with a regular meal.

Population:Healthy adults, 18–60 y

Participants:20 (10 men, 10 women)

Duration:24-h pharmacokinetics

Dose:3 g EPA+DHA, single dose (MAG vs EE)

Primary Area:Omega-3 absorption & bioavailability

Key Finding

Plasma EPA and DHA peaked ~3× and ~2.5× higher, respectively, with MAG than EE; absorption-phase n-3 FA concentration was on average 3–5× higher with MAG.

View on PubMed

RCTBranded Ingredient StudyStrong

Pharmacokinetics of supplemental omega-3 fatty acids in monoglycerides, ethyl esters, or triglycerides in adults with a regular meal: a randomized crossover trial

Current Developments in Nutrition, 2021

1.3 g of EPA+DHA in MAG-O3 was absorbed at least 2× better than the dose-equivalent re-esterified triglyceride (rTG) fish oil, even with a regular meal.

Population:Healthy adults, 18–50 y

Participants:22 (11 men, 11 women)

Duration:24-h pharmacokinetics

Dose:~1.2 g EPA+DHA, single dose (MAG vs EE vs TG)

Primary Area:Omega-3 absorption & bioavailability

Key Finding

The 24-h AUC of plasma EPA was ~2× higher after MAG than EE; EE and TG did not differ. The three forms showed similar gastrointestinal side effects.

View on PubMed

Frequently Asked Questions

What is monoglyceride omega-3?

Monoglyceride omega-3 is a form of fish oil in which EPA and DHA are positioned on the sn-2 position of glycerol as free monoglycerides. This structure can be absorbed directly across the intestinal wall.

What is the most absorbable form of fish oil?

Among ethyl ester, triglyceride, re-esterified triglyceride, and monoglyceride forms, pharmacokinetic research generally supports monoglyceride omega-3 as having the most direct absorption pathway. Individual results vary.

What is MAG-O3?

MAG-O3 is a branded monoglyceride omega-3 ingredient supplying EPA and DHA in the sn-2 monoglyceride structure.

How does monoglyceride omega-3 compare to ethyl ester fish oil?

Ethyl ester omega-3 requires enzymatic hydrolysis before absorption, while monoglyceride omega-3 is already in an absorbable molecular form, which research suggests supports higher bioavailability per dose.

What is the Omega-3 Index?

The Omega-3 Index is the percentage of EPA and DHA in red blood cell membranes, used as a long-term biomarker of omega-3 status. Different omega-3 forms raise the index at different rates.

Related Research

DeltaGold® Annatto Tocotrienols / Vitamin E Curcumin C3 Complex® Standardized Curcuminoid Complex Aquamin® Marine-Derived Multimineral Complex Magtein® Magnesium L-Threonate GlucoVantage® Dihydroberberine

Interested in formulating with clinically researched omega-3?

Explore Wellnex custom supplement formulation to build evidence-focused formulas around this ingredient.

Build a Formula Custom Formulation Services

FDA Disclaimer

These statements have not been evaluated by the Food and Drug Administration. The ingredients and research summarized on this page are provided for educational purposes only and are not intended to diagnose, treat, cure, or prevent any disease. Research findings reflect the published studies cited and do not represent claims about any Wellnex Solutions product. Individual results vary. Always consult a qualified healthcare professional before beginning any supplement regimen.